Delivery Order SPE2DB22D2214-SPE2DB25FS6FL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,668.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,889.08 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,108.80 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Refresh Plus 0.5% eye drops (30 units). This firm fixed price, non-set-aside contract is scheduled for completion by August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the Defense Logistics Agency's Medical Supply Chain operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.92 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops UD 70s, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement portfolio. The place of performance is listed as Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $1,125.76 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Refresh Plus 0.5% eye drops (30-unit package). This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,112.13 to AmerisourceBergen Drug Corp on August 8, 2025, for Refresh Plus 0.5% eye drops (70 unit dose packages). This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by August 11, 2025, with performance at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.27 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-unit package) on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,244.93 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on August 7, 2025, for Refresh Plus 0.5% eye drops in unit dose packaging (50 count). The contract is valued at $1,583.61 with a firm fixed price structure and an ultimate completion date of August 8, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6FLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,129.61 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops UD 50s on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order represents a routine pharmaceutical supply fulfillment under that strategic contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/21/25 |